A comprehensive study from Karolinska Institutet shows that people with fatty liver disease have almost twice the mortality ...

Endocrine-disease-focused Visen Pharmaceuticals is making its public market debut in Hong Kong, filing papers for an $86.5 ...

IceCure Medical (ICCM) announced it is in continued discussions with the U.S. FDA regarding its De Novo marketing authorization request for ...

John Amos, Dr. Farhad Zangeneh, Medical Director of Endocrine, Diabetes and Osteoporosis Clinic, Dr. Dina Peralta-Reich, New York Weight Wellness Medicine Founder and Director, and Peter Maher, a ...

The identification of BRP, an anti-obesity peptide, showcases the transformative role of AI in drug discovery and its ...

A new research paper was published by Aging (Aging-US) on March 7, 2025, titled "Accelerated aging associated with cancer characteristics and treatments among breast cancer survivors." ...